Patents by Inventor Kennett Sprogøe

Kennett Sprogøe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150290337
    Abstract: The present invention relates to apolymeric prodrug for use in the treatment, prevention and/or diagnosis a disease of the joint and pharmaceutical compositions and medical devices comprising said polymeric prodrugs.
    Type: Application
    Filed: October 8, 2013
    Publication date: October 15, 2015
    Inventors: Dirk Vetter, Ulrich Hersel, Kennett Sprogøe, Nora Kaluza, Oliver Keil, Guillaume Maitro, Harald Rau
  • Publication number: 20150010634
    Abstract: The present invention relates to pharmaceutical compositions comprising hydrogel-linked prodrug for use in the treatment, prevention and/or diagnosis a condition of the eye and ophthalmic devices comprising said pharmaceutical compositions.
    Type: Application
    Filed: October 11, 2012
    Publication date: January 8, 2015
    Applicant: Ascendis Pharma Ophthamology Division A/S
    Inventors: Thomas Knappe, Burkhardt Laufer, Harald Rau, Kennett Sprogøe, Tobias Voigt, Samuel Weisbrod
  • Publication number: 20140303245
    Abstract: The present invention relates to sustained release compositions of prostacyclin, as well as uses thereof, in particular for the prevention and/or treatment of pulmonary arterial hypertension.
    Type: Application
    Filed: August 10, 2012
    Publication date: October 9, 2014
    Applicant: Ascendis Pharma A/S
    Inventors: Kennett Sprogøe, Harald Rau, Ulrich Hersel, Thomas Wegge, Oliver Keil, Joachim Zettler
  • Publication number: 20140296150
    Abstract: The present invention relates to prodrugs or a pharmaceutically acceptable salt thereof comprising a covalent treprostinil carrier conjugate as well as pharmaceutical composition comprising said compounds. The compounds may be used as medicaments, especially for diseases or disorders which can be treated by treprostinil, such as pulmonary arterial hypertension (PAH).
    Type: Application
    Filed: August 10, 2012
    Publication date: October 2, 2014
    Applicant: Ascendis Pharma A/S
    Inventors: Ulrich Hersel, Harald Rau, Torben Lessmann, Nicola Bisek, Guillaume Maitro, Kennett Sprogøe, Thomas Wegge, Oliver Keil, Joachim Zettler
  • Patent number: 8758780
    Abstract: The present invention relates to pharmaceutical composition for subcutaneous injection comprising a paliperidone compound wherein the composition releases the paliperidone with an immediate onset of action and continuously for at least 3 weeks, and wherein the composition has a pharmacokinetic profile in vivo with substantially no burst release of the paliperidone. The compositions are useful as medicaments for the treatment of psychotic disorders and diseases.
    Type: Grant
    Filed: October 6, 2010
    Date of Patent: June 24, 2014
    Assignee: Ascendis Pharma AS
    Inventors: Kennett Sprogøe, Ulrich Hersel, Harald Rau, Guillaume Maitro, Thomas Wegge
  • Publication number: 20120277253
    Abstract: The present invention relates to pharmaceutical composition for subcutaneous injection comprising a paliperidone compound wherein the composition releases the paliperidone with an immediate onset of action and continuously for at least 3 weeks, and wherein the composition has a pharmacokinetic profile in vivo with substantially no burst release of the paliperidone. The compositions are useful as medicaments for the treatment of psychotic disorders and diseases.
    Type: Application
    Filed: October 6, 2010
    Publication date: November 1, 2012
    Inventors: Kennett Sprogøe, Ulrich Hersel, Harald Rau, Guillaume Maitro, Thomas Wegge